ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Velcade Addition Can Improve Graft-Versus-Host Outcomes

December 27, 2013

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

Treat Cancer, But Protect Heart Anderson Cardiologists Warn

July 30, 2004

Freeman Reappointed President’s Cancer Panel Chairman

September 16, 1994

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986